Innovative retatrutide, a dual -action treatment targeting both GLP-1 and GIP receptors, is sparking considerable buzz within the weight loss community. Early clinical trials have shown impressive decreases in body weight and gains in metabolic markers for individuals with excess weight . Experts believe this unique approach has the potential to s